Request Trial

Marisa Woutersen

Key details

Marisa Woutersen is a senior reporter for Life Sciences Intellectual Property Review and World IP Review. She largely covers intellectual property developments across the global life sciences sector, including pharmaceuticals, biotechnology, medtech, AI, M&A and regulation.

Since joining Newton Media in 2023, Marisa has reported across a wide range of topics, from the rise of generative AI and its impact on the creative industries to the crossover between intellectual property and sport, including issues affecting athletes, as well as global pharmaceutical disputes, vaccine technology, access to medicines and life sciences M&A.

She has reported live from court and regularly travels to international conferences, where she interviews lawyers, business leaders and other key industry figures.

Marisa holds a Master’s in International Law and a BA in Politics and International Relations from the University of Sussex, and is currently completing her NCTJ Diploma in Journalism.

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine search
Total results: 456

Articles by Marisa Woutersen

Data and delivery: Inside AI's inventorship dilemma
Americas
Data and delivery: Inside AI's inventorship dilemma
Isomorphic Labs' head of IP shares why the first wave of AI-driven drug development stumbled, how data became pharma's most valuable currency, and why inventorship questions could make or break billion-dollar deals in machine learning.   21 October 2025
Weil continues expansion with top trade secrets litigator
Careers
Weil continues expansion with top trade secrets litigator
Hire brings trade secrets and AI litigation expertise from Cooley as firm adds 14th US litigation partner this year.   21 October 2025
Top pharma, biotech, and medtech experts gather at LSPN Fall
Americas
Top pharma, biotech, and medtech experts gather at LSPN Fall
LSIPR is gearing up for the 5th annual LSPN North America Fall Conference, starting October 21, in San Francisco, California.   21 October 2025
Europe
Novartis fails to block repackaged imports of blockbuster treatment
The court rejected Novartis’s request for emergency measures against a Spanish importer after the pharma company failed to meet the test to enforce an injunction, the winning lawyers told LSIPR.   16 October 2025
Americas
Protect early, partner wisely: In-house tips for medtech startups
In-house IP director at RefleXion talks about protecting complex medtech, why startups can't afford to cut corners on early decisions, and when to employ outside expertise.   15 October 2025
Careers
Morgan Lewis adds regulatory partner to London office
Hire brings experience across the pharmaceutical, medtech, cosmetics, and food sectors, advising clients on regulatory, policy, and compliance matters before UK and EU authorities.   14 October 2025
Americas
‘Death knell’ for investment: Universities warn against Lutnick’s royalty sharing proposal
A recent survey shows heavy opposition to the proposal which could leave university licensing struggling, chill investment in startups, and threaten technology transfers.   13 October 2025
Careers
Teva in-house counsel jumps to private practice
The hire brings experience managing global trademark, copyright, and domain portfolios, as well as prior in-house roles at Teva and Johnson & Johnson.   9 October 2025
Americas
Brazil’s patent shake-up: How pharma is handling a new reality
A 2021 Supreme Court ruling changed how patent terms are calculated, forcing pharma companies to rethink their IP strategies. Juliana Neves of Licks explains the key changes, upcoming reforms, and how companies can protect their portfolios effectively.   8 October 2025
Americas
Eli Lilly strikes AI drug discovery deal with US biotech
The pharma giant will share rights to new innovations with an AI-driven organoid platform designed to produce fully human antibodies in weeks.   7 October 2025

Not finding what you're looking for, please try resetting your applied search and filters,
or try the full site search.